Prokidney Corp
PROK
NASDAQ
Biotechnology
$1.33
USD
-0.08 (-5.34%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $424.02M
Volume 1.4M
Price Target
$12.00 – $12.00
USD
The 1 analysts offering 1-year price forecasts have a max estimate of $12.00 and a min estimate of $12.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$12.00
Implied Upside
+802.3%
Analyst Covering
1
Consensus
Buy
Signal Quality
Consensus Freshness
100%
Most ratings are recent - from the last 3 months
Analyst Agreement
High
Targets are closely clustered - analysts largely agree
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
1 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
1 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Joseph Pantginis | HC Wainwright & Co. | Buy | Reiterated | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
CAPR
Capricor Therapeutics Inc
$6.65
▲ +58.0%
XFOR
X4 Pharmaceuticals Inc
$4.22
▼ -1.6%
FENC
Fennec Pharmaceuticals Inc
$11.72
▼ -2.8%
RCKT
Rocket Pharmaceuticals Inc
$3.47
▲ +3.9%
EDIT
Editas Medicine Inc
$2.82
▲ +0.4%
ENTA
Enanta Pharmaceuticals Inc
$13.16
▼ -2.1%
LXEO
Lexeo Therapeutics Inc
$4.84
▼ -2.4%
BNTC
Benitec Biopharma Inc
$12.56
▲ 0.0%
CMPX
Compass Therapeutics Inc.
$2.25
▼ -0.4%